These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 23782649

  • 21. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 22. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au.
    Hypertension; 2011 May 01; 57(5):911-7. PubMed ID: 21403086
    [Abstract] [Full Text] [Related]

  • 23. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
    Fischell TA, Ebner A, Gallo S, Ikeno F, Minarsch L, Vega F, Haratani N, Ghazarossian VE.
    JACC Cardiovasc Interv; 2016 Mar 28; 9(6):589-98. PubMed ID: 27013159
    [Abstract] [Full Text] [Related]

  • 24. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
    Fengler K, Rommel KP, Blazek S, Besler C, Hartung P, von Roeder M, Petzold M, Winkler S, Höllriegel R, Desch S, Thiele H, Lurz P.
    Circulation; 2019 Jan 29; 139(5):590-600. PubMed ID: 30586691
    [Abstract] [Full Text] [Related]

  • 25. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
    Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP.
    Eur Heart J; 2014 Jul 29; 35(26):1752-9. PubMed ID: 24898552
    [Abstract] [Full Text] [Related]

  • 26. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H, Neuzil P, Skoda J, Petru J, Sediva L, Schejbalova M, Reddy VY.
    JACC Cardiovasc Interv; 2012 Jul 29; 5(7):758-65. PubMed ID: 22814781
    [Abstract] [Full Text] [Related]

  • 27. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie.
    Ann Cardiol Angeiol (Paris); 2013 Dec 29; 62(6):384-91. PubMed ID: 24182849
    [Abstract] [Full Text] [Related]

  • 28. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.
    Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G, Renal Denervation for Hypertension (DENERHTN) investigators.
    Lancet; 2015 May 16; 385(9981):1957-65. PubMed ID: 25631070
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease.
    Cai H, Fang Z, Wu X, Zhou W, Lin J, Peng F, Su J.
    J Clin Hypertens (Greenwich); 2024 Apr 16; 26(4):338-348. PubMed ID: 38430475
    [Abstract] [Full Text] [Related]

  • 30. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
    Weber MA, Kirtane AJ, Weir MR, Radhakrishnan J, Das T, Berk M, Mendelsohn F, Bouchard A, Larrain G, Haase M, Diaz-Cartelle J, Leon MB.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):461-470. PubMed ID: 32081240
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.
    Daemen J, Mahfoud F, Kuck KH, Andersson B, Böhm M, Graf T, Sievert H, Kahlert P, Iyer M, Zeller T.
    J Hypertens; 2019 Sep 24; 37(9):1906-1912. PubMed ID: 31045964
    [Abstract] [Full Text] [Related]

  • 32. [Renal artery denervation for treating refractory hypertension].
    Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.
    Ann Cardiol Angeiol (Paris); 2011 Dec 24; 60(6):354-60. PubMed ID: 22040858
    [Abstract] [Full Text] [Related]

  • 33. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H, Jiang X, Liang T, Zou Y, Guan T, Peng M, Song L, Zhang H, Wu H, Xu B, Yang Y, Gao R.
    J Invasive Cardiol; 2014 Jul 24; 26(7):322-7. PubMed ID: 24993989
    [Abstract] [Full Text] [Related]

  • 34. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F, Fezzi S, Gambaro A, Ederle F, Castaldi G, Widmann M, Gangemi C, Ferrero V, Pesarini G, Pighi M, Ribichini FL.
    J Nephrol; 2021 Oct 24; 34(5):1445-1455. PubMed ID: 33481223
    [Abstract] [Full Text] [Related]

  • 35. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
    Rosa J, Widimský P, Toušek P, Petrák O, Čurila K, Waldauf P, Bednář F, Zelinka T, Holaj R, Štrauch B, Šomlóová Z, Táborský M, Václavík J, Kociánová E, Branny M, Nykl I, Jiravský O, Widimský J.
    Hypertension; 2015 Feb 24; 65(2):407-13. PubMed ID: 25421981
    [Abstract] [Full Text] [Related]

  • 36. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2015 Dec 24; 104(12):1097-105. PubMed ID: 26306594
    [Abstract] [Full Text] [Related]

  • 37. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M, SPYRAL HTN-OFF MED trial investigators*.
    Lancet; 2017 Nov 11; 390(10108):2160-2170. PubMed ID: 28859944
    [Abstract] [Full Text] [Related]

  • 38. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 11; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 39. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.
    Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD.
    Lancet; 2014 Feb 15; 383(9917):622-9. PubMed ID: 24210779
    [Abstract] [Full Text] [Related]

  • 40. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L, Ewen S, Tzafriri AR, Edelman ER, Cremers B, Kulenthiran S, Ukena C, Linz D, Kindermann I, Tsioufis C, Scheller B, Böhm M, Mahfoud F.
    Cardiovasc Revasc Med; 2018 Feb 15; 19(7 Pt B):845-851. PubMed ID: 29555535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.